Literature DB >> 20844876

[Changes in the TNM classification of gynecological tumors].

L-C Horn1, M W Beckmann, A Beller, D Schmidt, U Ulrich, P Hantschmann, C Wittekind.   

Abstract

Based on the results of clinical and histomorphological studies in recent years, a revision of the TNM classification of malignant tumours of the female genital organs became necessary. Vulvar cancer saw the most significant changes. In the T1 category the new system recognises tumour size and its relation to the infiltration of adjacent structures by the tumour. The number of positive regional lymph nodes has also been included in the new staging system. For cervical cancer, there is a new subdivision of the category T2a depending on tumour size with a breakpoint of ≤ 4 cm versus > 4 cm and a subdivision into T2a1 und T2a2. In endometrial cancer, the previous pT1a and pT1b were merged to pT1a. The former category T1c has changed into T1b. The category pT1c is no longer used. For the first time, there is a TNM classification system for uterine sarcomas.

Entities:  

Mesh:

Year:  2010        PMID: 20844876     DOI: 10.1007/s00292-010-1308-z

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  47 in total

1.  The prognostic significance of peritoneal cytology for stage I endometrial cancer.

Authors:  D A Turner; D M Gershenson; N Atkinson; N Sneige; A T Wharton
Journal:  Obstet Gynecol       Date:  1989-11       Impact factor: 7.661

2.  Carcinoma of the vulva. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

Authors:  U Beller; M A Quinn; J L Benedet; W T Creasman; H Y S Ngan; P Maisonneuve; S Pecorelli; F Odicino; A P M Heintz
Journal:  Int J Gynaecol Obstet       Date:  2006-11       Impact factor: 3.561

3.  Squamous vulvar intraepithelial neoplasia: 2004 modified terminology, ISSVD Vulvar Oncology Subcommittee.

Authors:  Mario Sideri; Ronald W Jones; Edward J Wilkinson; Mario Preti; Debra S Heller; James Scurry; Hope Haefner; Sallie Neill
Journal:  J Reprod Med       Date:  2005-11       Impact factor: 0.142

4.  [New FIGO staging for uterine sarcomas].

Authors:  L-C Horn; D Schmidt; C Fathke; U Ulrich
Journal:  Pathologe       Date:  2009-07       Impact factor: 1.011

5.  Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals.

Authors:  W T Creasman; P J Disaia; J Blessing; R H Wilkinson; W Johnston; J C Weed
Journal:  Am J Obstet Gynecol       Date:  1981-12-15       Impact factor: 8.661

6.  Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study).

Authors:  H D Homesley; B N Bundy; A Sedlis; E Yordan; J S Berek; A Jahshan; R Mortel
Journal:  Am J Obstet Gynecol       Date:  1991-04       Impact factor: 8.661

7.  Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis.

Authors:  John K Chan; Valerie Sugiyama; Huyen Pham; Mai Gu; Joanne Rutgers; Kathryn Osann; Michael K Cheung; Michael L Berman; Philip J Disaia
Journal:  Gynecol Oncol       Date:  2006-11-07       Impact factor: 5.482

8.  Prognostic value of peritoneal cytology in endometrial carcinoma.

Authors:  R N Grimshaw; W C Tupper; R C Fraser; M G Tompkins; J F Jeffrey
Journal:  Gynecol Oncol       Date:  1990-01       Impact factor: 5.482

9.  Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study.

Authors:  R C Boronow; C P Morrow; W T Creasman; P J Disaia; S G Silverberg; A Miller; J A Blessing
Journal:  Obstet Gynecol       Date:  1984-06       Impact factor: 7.661

10.  Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus.

Authors:  T Kasamatsu; T Onda; N Katsumata; M Sawada; T Yamada; R Tsunematsu; K Ohmi; Y Sasajima; Y Matsuno
Journal:  Br J Cancer       Date:  2003-01-27       Impact factor: 7.640

View more
  1 in total

1.  Reactivation of codogenic endogenous retroviral (ERV) envelope genes in human endometrial carcinoma and prestages: Emergence of new molecular targets.

Authors:  Pamela L Strissel; Matthias Ruebner; Falk Thiel; David Wachter; Arif B Ekici; Friedericke Wolf; Franziska Thieme; Klemens Ruprecht; Matthias W Beckmann; Reiner Strick
Journal:  Oncotarget       Date:  2012-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.